For the quarter ending 2025-06-30.
| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Unrealized (loss) gain on short-term investments (note 4) | -7,152 | |||
| Net loss for the period | -4,003,274 | |||
| Loss and comprehensive loss for the period | -4,010,426 | |||
| Earnings per share, basic | -0.09 | |||
| Earnings per share, diluted | -0.09 | |||
| Weighted average number of shares outstanding, basic | 44,388,550 | |||
| Weighted average number of shares outstanding, diluted | 44,388,550 | |||
ESSA Pharma Inc. (EPIX)
ESSA Pharma Inc. (EPIX)